Form 8-K - Current report:
SEC Accession No. 0001193125-24-263748
Filing Date
2024-11-22
Accepted
2024-11-22 06:16:01
Documents
19
Period of Report
2024-11-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d901268d8k.htm   iXBRL 8-K 48502
2 EX-99.1 d901268dex991.htm EX-99.1 16650
7 GRAPHIC g914468g1122072231997.jpg GRAPHIC 5594
8 GRAPHIC g914468g1122072232251.jpg GRAPHIC 844
9 GRAPHIC g914468g1122072232468.jpg GRAPHIC 854
10 GRAPHIC g914468g1122072232679.jpg GRAPHIC 964
  Complete submission text file 0001193125-24-263748.txt   250494

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20241121.xsd EX-101.SCH 4472
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20241121_def.xml EX-101.DEF 13890
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20241121_lab.xml EX-101.LAB 23246
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20241121_pre.xml EX-101.PRE 14859
22 EXTRACTED XBRL INSTANCE DOCUMENT d901268d8k_htm.xml XML 6193
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 241486329
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)